Form 8-K - Current report:
SEC Accession No. 0000950170-24-123280
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:19
Documents
13
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20241107.htm   iXBRL 8-K 45389
2 EX-99.1 lbph-ex99_1.htm EX-99.1 179078
3 GRAPHIC img58896055_0.jpg GRAPHIC 11946
  Complete submission text file 0000950170-24-123280.txt   381030

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20241107.xsd EX-101.SCH 32374
15 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20241107_htm.xml XML 5113
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 241435502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)